NCBI Taxonomy: 1862675
Sclerophrys (ncbi_taxid: 1862675)
found 44 associated metabolites at genus taxonomy rank level.
Ancestor: Bufonidae
Child Taxonomies: Sclerophrys garmani, Sclerophrys maculata, Sclerophrys xeros, Sclerophrys brauni, Sclerophrys poweri, Sclerophrys kisoloensis, Sclerophrys asmarae, Sclerophrys dodsoni, Sclerophrys funerea, Sclerophrys pentoni, Sclerophrys perreti, Sclerophrys pusilla, Sclerophrys arabica, Sclerophrys capensis, Sclerophrys pardalis, Sclerophrys taiensis, Sclerophrys tuberosa, Sclerophrys lemairii, Sclerophrys tihamica, Sclerophrys latifrons, Sclerophrys regularis, Sclerophrys villiersi, Sclerophrys togoensis, Sclerophrys channingi, Sclerophrys blanfordii, Sclerophrys gutturalis, Sclerophrys pantherina, Sclerophrys gracilipes, Sclerophrys mauritanica, unclassified Sclerophrys, Sclerophrys camerunensis, Sclerophrys superciliaris, Sclerophrys steindachneri, Sclerophrys cf. garmani HCL-2014, Sclerophrys cf. tuberosa HCL-2014, Sclerophrys cf. regularis FB-2010, Sclerophrys cf. regularis JWS 764, Sclerophrys cf. gutturalis FP-2020, Sclerophrys cf. gracilipes HCL-2017, Sclerophrys cf. gracilipes HCL-2014, Sclerophrys cf. kisoloensis HCL-2014
Bufogein
Bufogenin is a steroid lactone of Chan su (toad venom), a Chinese medicine obtained from the skin venom gland of toads. A specific Na/K-ATPase protein inhibitor, it is used as a cardiotonic and central nervous system (CNS) respiratory agent, an analgesic and anesthetic, and as a remedy for ulcers. It has a role as an EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor. It is a steroid lactone and an epoxy steroid. It is functionally related to a bufanolide. Resibufogenin is a natural product found in Sclerophrys mauritanica, Bufo gargarizans, and other organisms with data available. Bufogenin is a bufadienolide toxin originally isolated from the venom of the Chinese toad Bufo gargarizans; it is also one of the glycosides in the traditional Chinese medicine ChanSu, with potential cardiotonic activity. Although the mechanism of action of bufogenin is still under investigation, this agent is a specific Na+/K+-ATPase inhibitor and has been shown to reduce blood pressure in a rat model of preeclampsia. D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides D002317 - Cardiovascular Agents C471 - Enzyme Inhibitor Resibufogenin is a component of cinobufogenin and has the function of inhibiting oxidative stress and tumor regeneration. Resibufogenin is a component of cinobufogenin and has the function of inhibiting oxidative stress and tumor regeneration.
Hellebrigenin
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides
Marinobufagin
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents D004791 - Enzyme Inhibitors
Bufogenin
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides D002317 - Cardiovascular Agents
Marinobufagenin
14,15beta-Epoxy-3beta,5-dihydroxy-19-oxo-5beta,14beta-bufa-20,22-dienolid|14,15beta-epoxy-3beta,5-dihydroxy-19-oxo-5beta,14beta-bufa-20,22-dienolide|bufotalinin
Resibufogenin
Annotation level-1 Resibufogenin is a component of cinobufogenin and has the function of inhibiting oxidative stress and tumor regeneration. Resibufogenin is a component of cinobufogenin and has the function of inhibiting oxidative stress and tumor regeneration.
Marinobufogenin
D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002301 - Cardiac Glycosides D020011 - Protective Agents > D002316 - Cardiotonic Agents > D002018 - Bufanolides D002317 - Cardiovascular Agents > D014662 - Vasoconstrictor Agents D004791 - Enzyme Inhibitors